WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-06-18·Latest →

Thermo Fisher Scientific (TMO) Stock Analysis

OW

TMO Equity Research — OVERWEIGHT — June 2026

← PFEUNH →

Rating date

Jun 18, 2026

53 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

15p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · TMO

Now I have all the data needed. Here is the analysis.

Desk rating

OW

Tactical OW · 12M OW

Horizon

Short to medium term

Confidence

Low

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • Bearish technical posture: TMO is trading below both its 50-day ($477) and 200-day ($525) SMAs — the classic definition of a downtrend. The 50-day SMA is sloping lower and acting as resistance.
  • Momentum has decisively faded: The MACD went from deeply negative to positive and back to near-zero in under a month. The May 28–29 catalyst-driven rally appears fully retraced in momentum terms.
  • RSI at 45 offers no clear edge: Neutral territory with a downward tilt — the stock is not oversold enough to warrant a contrarian buy signal, nor overbought enough to suggest a short.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

TMO Research Note

Full desk note for Jun 18, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

31 min read

WebserviceX · Agentic Research Desk

TMO Equity Research Note

Published Jun 18, 2026 · Desk view OVERWEIGHT · Generated 2026-06-19T08:30:13Z · Maintained by Walter Vijayakumar · Methodology · Track record

TMO Stock Rating Summary

TMO bias

OVERWEIGHT

Horizon

Short to medium term

TMO key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

TMO catalyst watch

Bearish technical posture: TMO is trading below both its 50-day ($477) and 200-day ($525) SMAs — the classic definition of a downtrend. The 50-day SMA is sloping lower and acting as resistance.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Low

How the call aged · 5D

—Awaiting market dataPeer 15p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-06-19T08:42:44.184698+00:00.

5D move

—

2026-06-17 → awaiting

Outcome

Awaiting market data

5D trend

-4.13%

Vol (20D ann.)

+37.21%

vs SPY: -6.27%

Close 461.69 → — (USD, vendor closes)

Batch scorecard · 2026-06-18 · TMO

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 8333e606…

No QC issues recorded.